BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32661136)

  • 1. ΔNp63-Regulated Epithelial-to-Mesenchymal Transition State Heterogeneity Confers a Leader-Follower Relationship That Drives Collective Invasion.
    Westcott JM; Camacho S; Nasir A; Huysman ME; Rahhal R; Dang TT; Riegel AT; Brekken RA; Pearson GW
    Cancer Res; 2020 Sep; 80(18):3933-3944. PubMed ID: 32661136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An epigenetically distinct breast cancer cell subpopulation promotes collective invasion.
    Westcott JM; Prechtl AM; Maine EA; Dang TT; Esparza MA; Sun H; Zhou Y; Xie Y; Pearson GW
    J Clin Invest; 2015 May; 125(5):1927-43. PubMed ID: 25844900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ΔNp63α Promotes Breast Cancer Cell Motility through the Selective Activation of Components of the Epithelial-to-Mesenchymal Transition Program.
    Dang TT; Esparza MA; Maine EA; Westcott JM; Pearson GW
    Cancer Res; 2015 Sep; 75(18):3925-35. PubMed ID: 26292362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells.
    Wu J; Li WZ; Huang ML; Wei HL; Wang T; Fan J; Li NL; Ling R
    Biochem Biophys Res Commun; 2017 Jan; 483(1):10-16. PubMed ID: 28069384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
    Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z
    Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA LRRC75A-AS1 facilitates triple negative breast cancer cell proliferation and invasion via functioning as a ceRNA to modulate BAALC.
    Li S; Wu D; Jia H; Zhang Z
    Cell Death Dis; 2020 Aug; 11(8):643. PubMed ID: 32811810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.
    Ji H; Sang M; Liu F; Ai N; Geng C
    Pathol Res Pract; 2019 Apr; 215(4):697-704. PubMed ID: 30611621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine 1-phosphate signaling induces SNAI2 expression to promote cell invasion in breast cancer cells.
    Wang W; Hind T; Lam BWS; Herr DR
    FASEB J; 2019 Jun; 33(6):7180-7191. PubMed ID: 30844311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergetic Effects of Intronic Mature miR-944 and ΔNp63 Isoforms on Tumorigenesis in a Cervical Cancer Cell Line.
    Kim J; Park S; Chang Y; Park KH; Lee H
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32764455
    [No Abstract]   [Full Text] [Related]  

  • 10. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
    Sun G; Liu M; Han H
    J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ΔNp63α induces the expression of FAT2 and Slug to promote tumor invasion.
    Dang TT; Westcott JM; Maine EA; Kanchwala M; Xing C; Pearson GW
    Oncotarget; 2016 May; 7(19):28592-611. PubMed ID: 27081041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.
    Li YY; Zheng XH; Deng AP; Wang Y; Liu J; Zhou Q; Cheng GY; Jiang Q
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10433-10442. PubMed ID: 31841197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial fluid pressure regulates collective invasion in engineered human breast tumors via Snail, vimentin, and E-cadherin.
    Piotrowski-Daspit AS; Tien J; Nelson CM
    Integr Biol (Camb); 2016 Mar; 8(3):319-31. PubMed ID: 26853861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.
    Zhang FL; Cao JL; Xie HY; Sun R; Yang LF; Shao ZM; Li DQ
    Cancer Res; 2018 Oct; 78(20):5780-5792. PubMed ID: 30093560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-suppressive roles of ΔNp63β-miR-205 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma via targeting ZEB1 and ZEB2.
    Hashiguchi Y; Kawano S; Goto Y; Yasuda K; Kaneko N; Sakamoto T; Matsubara R; Jinno T; Maruse Y; Tanaka H; Morioka M; Hattori T; Tanaka S; Kiyoshima T; Nakamura S
    J Cell Physiol; 2018 Oct; 233(10):6565-6577. PubMed ID: 29150940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway.
    Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
    J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism].
    Rahimian A; Barati G; Mehrandish R; Mellati AA
    Mol Biol (Mosk); 2018; 52(3):474-481. PubMed ID: 29989579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
    Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
    J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP/TAZ activity.
    Cao D; Zhu GY; Lu Y; Yang A; Chen D; Huang HJ; Peng SX; Chen LW; Li YW
    Biomed Pharmacother; 2020 Sep; 129():110462. PubMed ID: 32768952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.